At a glance
ClinicalIndex Comparison RecordN/ACompleted· 13 enrolled
Drug / intervention
CAP UnScented +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Evaluation of the Sun Protection Factor (SPF) of Sunscreen Products According to the FDA Final Rule: Sunscreen Drug Products (2011)
In Brief
A clinical study evaluating CAP UnScented, CAP Herbal Mint, and 2 other interventions for Sunscreening Agents. Completed, enrolled 13 participants across 1 site.
Detailed Summary
The purpose of this study is to determine the static SPF of three sunscreen products (ChapStick Active Performance \[CAP\] UnScented, CAP Herbal Mint and CAP Mountain Berry) using the methodology described in the Food and Drug Administration (FDA) Final Rule (2011).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSunscreening Agents
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
First PostedNov 2021
Enrollment StartNov 2021
Primary CompletionDec 2021
TodayJul 2026
First PostedNov 5, 2021
Enrollment StartNov 8, 2021
Primary CompletionDec 15, 2021
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 4.7 years ago
Interventions
CAP UnScenteddrug
Sunscreen lip balm.
CAP Herbal Mintdrug
Sunscreen lip balm.
CAP Mountain Berrydrug
Sunscreen lip balm.
SPF Standard Sunscreendrug
SPF Standard (7 percent \[%\] Padimate-O and 3% Oxybenzone)